DD'S Cellar Dweller Stock Watch Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : DD'S Cellar Dweller Stock Watch

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Due Diligence who wrote ()	5/30/1999 3:49:00 PM
From: John R Resseger	Read Replies (1) of 598

ANTX... Bid .375 ask .405 3/8 13/32 Has cash of around .22 Partners SKB and US Navy pay for most of the research. Pasteur Merieux Conaught is another partner. Stock has been over $2 several times. Government has been slow publishing final phase 2 report on Oral Camylobactor vaccine. ( see Consumer Reports story on Infected Chicken) www.antexbiologics.com lots of neat patents. Company has been valued at close to $3 on various Biotech sites. Coming events... Stockholders meeting 6-10-99 Surgeon General releases Phase 2 Campy.....???? Late late late and for no good reason. Nothing bad in report as far as CEO knows, per conversation with me in the past fortnight. finance.yahoo.com This may or may not have relevance biz.yahoo.com CHICAGO, May 29 /PRNewswire/ -- Though powerful, broad-spectrum antibiotic medications have yielded untold clinical benefits, their widespread use since the 1980s has brought on new strains of bacteria that are resistant to commonly prescribed antibiotics...... ....Eliopoulos addressed attendees at a scientific symposium hosted by bioMerieux, Inc., world leading supplier of infectious disease diagnostic products, and held prior to the American Society for Microbiology Annual Meeting here. He reported that even though the antibiotics introduced in the 1980s were significant breakthroughs, bacterial resistance developed over time, bringing about the need for new drugs and new ways to identify resistant strains of bacteria. Check out Antex diagnostic tools. Most of all check out Antex's patents on their platform technologies. NST and ART Think what Glaxo might pay for this now that Tagment goes for 10 cents instead of a buck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next